Work

Etiology of pediatric community-acquired pneumonia across Mycoplasma pneumoniae epidemic periods

Year: 2026
Type: article
Study design: Observational Study
Abstract: Community-acquired pneumonia (CAP) remains a leading cause of hospitalization and antibiotic use in children, yet etiologic data during Mycoplasma pneumoniae epidemic periods—now resurging globally after the COVID-19 pandemic—remain scarce. We conducted a nationwide prospective surveillance study across 17 hospitals in the Republic of Korea between September 2023 and May 2025, enrolling 740 children with CAP. Etiology was determined using standardized criteria: pyogenic bacteria by culture with central adjudication, atypical bacteria by polymerase chain reaction (PCR) and serology, and viral CAP by PCR (excluding human rhinovirus/enterovirus, bocavirus, and coronavirus, given their uncertain causal role). An etiologic pathogen was identified in 541 children (73.1%), with atypical pathogens predominating (43.6%), followed by viral (26.8%) and pyogenic (2.7%) etiologies. During the M. pneumoniae epidemic period (June–November 2024), atypical CAP accounted for approximately 65% of all enrolled cases, with a 68% reduction in the odds of pyogenic CAP compared with non-epidemic periods (odds ratio, 0.32; 95% confidence interval, 0.12–0.89). Despite its low prevalence, pyogenic CAP was independently associated with prolonged hospitalization, respiratory support, and intensive care unit admission. These findings suggest that routine empirical β-lactam coverage may be less warranted during M. pneumoniae epidemic periods, while early recognition of pyogenic CAP remains essential.
Language: English
Subfield: Epidemiology
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,690
OpenAlex ID: W7204191114
FWCI:
Cites:
Cited by:
Related to: